Bruce Keyt
54Patents
14h-index
66Co-inventors
87Inventor score
Filing activity: Jan 21, 1992 → Apr 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7628986B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 60 | Expired |
| US7423128B2 | Anti-properdin antibodies, and methods for making and using same | Chemistry; Metallurgy | 55 | Expired |
| US6057428A | Variants of vascular endothelial cell growth factor | Physics | 39 | Expired |
| US6020473A | Nucleic acids encoding variants of vascular endothelial cell growth factor | Physics | 38 | Expired |
| US7736644B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7973140B2 | Antibodies directed to angiopoietin-2 and uses thereof | Chemistry; Metallurgy | 27 | Expired |
| US5612029A | Tissue plasminogen activator glycosylation variants with improved therapeutic properties | Human Necessities | 17 | Expired |
| US9409976B2 | CDIM binding proteins and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US5246850A | DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells | Human Necessities | 17 | Expired |
| US9951134B2 | Modified J-chain | Chemistry; Metallurgy | 16 | Active |
| US9938347B2 | Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US10351631B2 | Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies | Chemistry; Metallurgy | 14 | Active |
| US10400038B2 | Modified J-chain | Chemistry; Metallurgy | 14 | Active |
| US6750044B1 | Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids | Chemistry; Metallurgy | 14 | Expired |
| US10604559B2 | Multi-valent hepatitis B virus antigen binding molecules and uses thereof | Physics | 13 | Active |
| US9096672B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US5385732A | Variants of tissue plasminogen activator, compositions and methods of use for same | Chemistry; Metallurgy | 13 | Expired |
| US10618978B2 | Binding molecules with modified J-chain | Chemistry; Metallurgy | 13 | Active |
| US10689449B2 | Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US5520911A | Variants of plasminogen activators and processes for their production | Chemistry; Metallurgy | 9 | Expired |
| US7427596B2 | Variants of vascular endothelial cell growth factor, their uses, and processes for their production | Physics | 9 | Expired |
| US5270198A | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells | Chemistry; Metallurgy | 9 | Expired |
| US7572444B2 | Binding proteins specific for human matriptase | Physics | 9 | Expired |
| US8362215B2 | Antibodies immunoreactive with heregulin-coupled HER3 | Chemistry; Metallurgy | 8 | Active |
| US7736648B2 | Anti-RSV G protein antibodies | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.